Travers K - Search Results

1

Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes.

Kanki P, M'Boup S, Marlink R, Travers K, Hsieh CC, Gueye A, Boye C, Sankalé JL, Donnelly C, Leisenring W, et al. Kanki P, et al. Among authors: travers k. Am J Epidemiol. 1992 Oct 1;136(7):895-907. doi: 10.1093/aje/136.7.895. Am J Epidemiol. 1992. PMID: 1442755

2

Slower heterosexual spread of HIV-2 than HIV-1.

Kanki PJ, Travers KU, MBoup S, Hsieh CC, Marlink RG, Gueye-NDiaye A, Siby T, Thior I, Hernandez-Avila M, Sankalé JL, et al. Kanki PJ, et al. Among authors: travers ku. Lancet. 1994 Apr 16;343(8903):943-6. doi: 10.1016/s0140-6736(94)90065-5. Lancet. 1994. PMID: 7909009

3

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.

Popper SJ, Sarr AD, Travers KU, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Popper SJ, et al. Among authors: travers ku. J Infect Dis. 1999 Oct;180(4):1116-21. doi: 10.1086/315010. J Infect Dis. 1999. PMID: 10479138

4

Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype.

Sarr AD, Sankalé JL, Hamel DJ, Travers KU, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Sarr AD, et al. Among authors: travers ku. Virology. 2000 Mar 15;268(2):402-10. doi: 10.1006/viro.2000.0192. Virology. 2000. PMID: 10704348 Free article.

5

Natural protection against HIV-1 infection provided by HIV-2.

Travers K, Mboup S, Marlink R, Guèye-Nidaye A, Siby T, Thior I, Traore I, Dieng-Sarr A, Sankalé JL, Mullins C, et al. Travers K, et al. Science. 1995 Jun 16;268(5217):1612-5. doi: 10.1126/science.7539936. Science. 1995. PMID: 7539936

6

Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa.

Kanki PJ, M'Boup S, Ricard D, Barin F, Denis F, Boye C, Sangare L, Travers K, Albaum M, Marlink R, et al. Kanki PJ, et al. Among authors: travers k. Science. 1987 May 15;236(4803):827-31. doi: 10.1126/science.3033826. Science. 1987. PMID: 3033826

7

Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, et al. Marlink R, et al. Among authors: travers k. Science. 1994 Sep 9;265(5178):1587-90. doi: 10.1126/science.7915856. Science. 1994. PMID: 7915856

8

Protection from HIV-1 infection by HIV-2.

Travers KU, Eisen GE, Marlink RG, Essex ME, Hsieh CC, Mboup S, Kanki PJ. Travers KU, et al. AIDS. 1998 Jan 22;12(2):224-5. AIDS. 1998. PMID: 9468377 No abstract available.

9

Response: HIV-2 and Natural Protection Against HIV-1 Infection.

Kanki PJ, Eisen G, Travers KU, Marlink RG, Essex ME, Hsieh CC, Mboup S. Kanki PJ, et al. Among authors: travers ku. Science. 1996 Jun 28;272(5270):1959b-60b. doi: 10.1126/science.272.5270.1959b. Science. 1996. PMID: 17774134 No abstract available.

10

Plasma RNA viral load as measured by the branched DNA and nucleic acid sequence-based amplification assays of HIV-1 subtypes A and D in Uganda.

Mani I, Cao H, Hom D, Johnson JL, Mugerwa RD, Travers KU, Caliendo AM, Walker BD, Kanki PJ. Mani I, et al. Among authors: travers ku. J Acquir Immune Defic Syndr. 1999 Oct 1;22(2):208-9. doi: 10.1097/00126334-199910010-00016. J Acquir Immune Defic Syndr. 1999. PMID: 10843537 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page